Good morning :)
$
₹
CELLYAN+BIOTECH+CO+LTD

CELLYAN+BIOTECH+CO+LTD

HKPD

US
Asset Logo

CELLYAN+BIOTECH+CO+LTD

HKPD

US
$2.178.5% (+0.17)
$
₹
$2.178.5% (+0.17)
High
—
—
Low
—
—
Returns
—
—
Loading...
1D
1W
1M
3M
6M
1Y
3Y
5Y
Max

Healthcare

Medical Distribution

Micro Cap

With a market cap of $246.6k the stock is ranked 6264

Key Metrics

Key Metrics

PE TTM
PE TTM

Close price divided by the earnings per share for the trailing twelve months

—
PB
PB

Close price divided by the book value per share at the end of the most recent quarter

0.64
EPS TTM
EPS TTM

Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)

$-1.38
PEG Ratio
PEG Ratio

Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years

—
Profit Margin
Profit Margin

Net profit divided by the total revenue for the most recent financial year

-8.46%
Dividend Yield
Dividend Yield

Annual dividend per share for the trailing twelve months divided by the close price

—

Company Profile

Company Profile

Cellyan Biotechnology Co., Ltd, an investment holding company, engages in the over-the counter (OTC) pharmaceutical business in Hong Kong and Mainland China. The company provides OTC pharmaceutical cross-border procurement and distribution and e-commerce supply chain services. It also offers customs clearance, drugs enlisting, warehouse, and other logistics services. In addition, it provides value-added services such as labeling, extended storage, product inspection, batch processing, and logistics support, as well as sales of health supplements and non-pharmaceutical products. The company serves e-commerce platform logistics partners, merchants, and Chinese e-commerce platforms as well as pharmaceutical distributors. The company was formerly known as Hong Kong Pharma Digital Technology Holdings Limited and changed its name to Cellyan Biotechnology Co., Ltd in December 2025. Cellyan Biotechnology Co., Ltd was incorporated in 2023 and is based in Yau Tong, Hong Kong.
Cellyan Biotechnology Co., Ltd, an investment holding company, engages in the over-the counter (OTC) pharmaceutical business in Hong Kong and Mainland China. The company provides OTC pharmaceutical cross-border procurement and distribution and e-commerce supply chain services. It also offers customs clearance, drugs enlisting, warehouse, and other logistics services. In addition, it provides value-added services such as labeling, extended storage, product inspection, batch processing, and logistics support, as well as sales of health supplements and non-pharmaceutical products. The company serves e-commerce platform logistics partners, merchants, and Chinese e-commerce platforms as well as pharmaceutical distributors. The company was formerly known as Hong Kong Pharma Digital Technology Holdings Limited and changed its name to Cellyan Biotechnology Co., Ltd in December 2025. Cellyan Biotechnology Co., Ltd was incorporated in 2023 and is based in Yau Tong, Hong Kong.

Peers

Compare with peers Compare with peers 

Peers

Compare with peers Compare with peers 
United Parcel Service Inc
UPS
United Parcel Service Inc
P/E Ratio
18.78
18.78
1Y Return
14.39%
14.39%
Buy Reco %
48.27
48.27
FedEx Corporation
FDX
FedEx Corporation
P/E Ratio
16.10
16.10
1Y Return
21.52%
21.52%
Buy Reco %
71.42
71.42
Expeditors International of Washington, Inc.
EXPD
Expeditors International of Washington, Inc.
P/E Ratio
28.56
28.56
1Y Return
64.17%
64.17%
Buy Reco %
16.66
16.66
XPO Logistics Inc
XPO
XPO Logistics Inc
P/E Ratio
53.88
53.88
1Y Return
45.56%
45.56%
Buy Reco %
80.00
80.00
CH Robinson Worldwide Inc
CHRW
CH Robinson Worldwide Inc
P/E Ratio
26.94
26.94
1Y Return
8.59%
8.59%
Buy Reco %
78.26
78.26
Compare with Peers

Forecast

Forecast

empty forecast

Forecast data is currently unavailable

Forecast data is currently unavailable

Price

Price Upside

Revenue

Revenue Growth

Earnings

Earnings Per Share

Financials

Financials

Income

Balance Sheet

Cash Flow

7.1
0.1
6.2
-1.2
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Revenue
Net Income
Financial YearQ1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
Total Revenue9.675.5411.094.619.224.61-7.13-6.29
Net Income1.080.410.82-0.42-0.85-0.42-0.15--1.28
Net Profit Margin11.16%7.47%7.47%-9.27%-9.27%-9.27%-2.15%--20.48%
See CostsAll values in $ Million

Peers

Peers & Comparison

Peers & Comparison

Comparing 2 stocks from
HealthcareMedical Distribution

Valuation

Returns

Forecast

ScreenerCompare valuation on Screener
StockPE TTMPE TTMPBPBPEG RatioPEG Ratio
CELLYAN+BIOTECH+CO+LTD -0.64-
United Parcel Service Inc18.785.411.36
FedEx Corporation16.102.331.31
ScreenerCompare valuation on Screener

Price Comparison

Price Comparison

Compare HKPD with any stock or ETF
Compare HKPD with any stock or ETF
Comparing from
HKPD
UPS
FDX
Loading...

Frequently asked questions

  1. CELLYAN+BIOTECH+CO+LTD (HKPD) share price today is $2.17 as of October 27, 2026 at 1:29 AM IST. The stock touched a day high of $2.19 and a day low of $1.88.

  2. CELLYAN+BIOTECH+CO+LTD stock trades on US under the ticker symbol HKPD.

  3. CELLYAN+BIOTECH+CO+LTD's market capitalization is $246.6K as of October 27, 2026 at 1:29 AM IST.

  4. CELLYAN+BIOTECH+CO+LTD's price-to-earnings (P/E) ratio is N/A as of October 26, 2026.

  5. CELLYAN+BIOTECH+CO+LTD's price-to-book (P/B) ratio is 0.64 as of October 26, 2026.

  6. Yes, You can buy CELLYAN+BIOTECH+CO+LTD shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.

  7. Indian investors can buy CELLYAN+BIOTECH+CO+LTD shares in three steps: 1. Search CELLYAN+BIOTECH+CO+LTD on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.

  8. Since CELLYAN+BIOTECH+CO+LTD trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.

  9. Indian investors can start investing in CELLYAN+BIOTECH+CO+LTD (HKPD) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 4.6082 shares at the current price of $2.17.

Loading...